View graph of relations
  1. 2019
  2. Published
  3. 2018
  4. Published
  5. Published
  6. Published
  7. Published
  8. 2017
  9. Published
  10. Published
  11. Published
  12. Published
  13. Published
  14. Published
  15. Published
  16. Published
  17. 2016
  18. Published
  19. Published
  20. Published
  21. Published
  22. Published
  23. 2015
  24. Published
  25. Published
  26. Published
  27. Published
  28. Published
  29. Published
  30. Published
    Wesseling, G., Muris, J. W. M., & Neef, C. (2015). Longziekten. In J. J. E. V. Everdingen, A. F. A. M. Schobben, & T. Wiersma (Eds.), Diagnose en therapie 2015-2016 (pp. 383-404). Bohn Stafleu van Loghum. https://doi.org/10.1007/978-90-368-0610-7_11
  31. Published
  32. Published
  33. Published
  34. 2014
  35. Published
  36. Published
    Haeseker, M. B., Croes, S., Neef, C., Bruggeman, C. A., Stolk, L. M. L., & Verbon, A. (2014). Vancomycin Dosing in Neutropenic Patients. PLOS ONE, 9(11), [e112008]. https://doi.org/10.1371/journal.pone.0112008
  37. Published
  38. Published
  39. Published
  40. Published
  41. Published
    Wong, D. R., Pierik, M., Seinen, M. L., van Bodegraven, A. A., Gilissen, L. P. L., Bus, P., ... Hooymans, P. M. (2014). The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients. Journal of Crohn's & Colitis, 8(2), 120-128. https://doi.org/10.1016/j.crohns.2013.07.004
  42. Published
    van Ganzewinkel, C., Derijks, L., Anand, K. J. S., van Lingen, R. A., Neef, C., Kramer, B. W., & Andriessen, P. (2014). Multiple intravenous doses of paracetamol result in a predictable pharmacokinetic profile in very preterm infants. Acta Paediatrica, 103(6), 612-617. https://doi.org/10.1111/apa.12638
  43. Published
  44. 2013
  45. Published
  46. Published
  47. Published
  48. Published
    van Leeuwen, R., Brundel, D. H., Neef, C. K., van Gelder, T., Mathijssen, R. H., Burger, D. M., & Jansman, F. G. (2013). Prevalence of potential drug-drug interactions in cancer patients treated with oral anticancer drugs. British Journal of Cancer, 108(5), 1071-1078. https://doi.org/10.1038/bjc.2013.48
  49. Published
  50. Published
  51. Published
  52. Published
  53. Published
  54. 2012
  55. Published
  56. Published
  57. Published
  58. 2010
  59. Published
  60. Published
  61. Published
  62. 2008
  63. Published
  64. Published
  65. 2007
  66. Published
  67. Published
  68. Published
  69. Published